Regorafenib monotherapy as second-line treatment of patients with RAS-mutant advanced colorectal cancer (STREAM): an academic, multicenter, single-arm, two-stage, phase II studyClaudia Cardone, Antonio Avallone, Gerardo Rosati et al.|ESMO Open|2023Cited by 6